Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry

PHASE4CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

June 27, 2014

Primary Completion Date

May 28, 2019

Study Completion Date

December 24, 2020

Conditions
Heroin DependenceOpioid-Related Disorders
Interventions
DRUG

Extended-Release Naltrexone

Extended-Release Naltrexone (Vivitrol®), 380mg administered 1x/month by intramuscular injection.

Trial Locations (2)

10016

Bellevue Hospital Center, New York

11370

NYC Department of Corrections: Rikers Island Jail Facilities, New York

Sponsors
All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

collaborator

Friends Research Institute, Inc.

OTHER

collaborator

University of California, Los Angeles

OTHER

lead

NYU Langone Health

OTHER